Related Experiment Video
Updated: Nov 19, 2025

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Mortality of COVID-19 patients with vascular thrombotic complications
José A Gonzalez-Fajardo1, Marina Ansuategui1, Carmen Romero2
1Servicio de Medicina Preventiva, Hospital Universitario 12 de Octubre, Madrid, Spain.
Insights
COVID-19 patients with vascular thrombosis face high mortality, especially with arterial events like peripheral arterial thrombosis (PAT) and ischemic stroke. Venous thromboembolism (VTE) is more common, but survival is better for deep vein thrombosis (DVT) and pulmonary embolism (PE).
Area of Science:
- Internal Medicine
- Cardiology
- Infectious Diseases
Background:
- COVID-19 is associated with an increased risk of vascular thrombotic complications.
- Understanding the specific risks and outcomes of different thrombotic events in COVID-19 patients is crucial for clinical management.
Purpose of the Study:
- To analyze the survival rates of hospitalized COVID-19 patients who experienced vascular thrombotic complications.
- To compare the mortality associated with different types of thrombosis, including deep vein thrombosis (DVT), pulmonary embolism (PE), ischemic stroke, and peripheral arterial thrombosis (PAT).
Main Methods:
- A cohort of 2943 COVID-19 patients admitted between March and April 2020 was analyzed.
- 106 patients with objectively confirmed symptomatic vascular thrombosis (DVT, PE, ischemic stroke, PAT) were identified.
- Survival analysis was performed using Kaplan-Meier curves, Log Rank test, and Cox regression.
Main Results:
- Vascular thrombosis occurred in 106 (3.6%) of COVID-19 patients, with PE being the most frequent (58 cases).
- Mortality was significantly higher in patients with arterial thrombosis (PAT: 69.2%, ischemic stroke: 53.3%) compared to venous thrombosis (DVT: 5%, PE: 12.1%).
- Overall hospital mortality for patients with vascular thrombosis was 23.58% (25 deaths).
Conclusions:
- While venous thromboembolism (VTE) is more common in COVID-19, arterial thrombosis (AT) carries a substantially higher mortality risk.
- Survival outcomes were poorer for patients with ischemic stroke and PAT compared to those with DVT and PE.
- These findings highlight the critical need for vigilant monitoring and management of thrombotic complications in COVID-19 patients.
Purpose:
To analyze the survival of patients hospitalized with COVID-19 and who presented some vascular thrombotic complication.
Material And Methods:
All consecutive patients with COVID-19 who were treated during the months of March and April 2020 at our institution were included. All patients were symptomatic and the thrombotic event objectively confirmed. Patients with deep vein thrombosis (DVT), pulmonary embolism (PE), ischemic stroke, and peripheral arterial thrombosis (PAT) were included. Survival curves for all groups were analyzed using Kaplan-Meier with Log Rank test, and Cox regression.
Results:
During the pandemic period from March-1 to April-30, 2943 patients were treated with confirmed COVID-19 in our center. 106 patients showed some symptomatic vascular thrombosis: 13 patients had PAT, 15 ischemic stroke, 20 DVT and 58 PE. 11 patients presented multiple vascular thrombosis. Although the mean age was 65 years, there were differences between groups being older those patients with arterial thrombosis. A 67.92% were men. In total, 25 patients died during their hospital admission (23.58%), with differences between groups, being more common in patients with PAT (9 patients out of 13) and ischemic stroke (8 patients out of 15), than in those with DVT (1 patient out of 20) or PE (7 patients out of 58).
Conclusions:
The venous thromboembolic risk in these patients is greater than the arterial, but arterial thrombosis when it occurs was associated with high mortality rates. Survival was better in patients with DVT and PE than in patients with ischemic stroke or PAT.
More Related Videos
07:56Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis
Published on: May 5, 2023
09:19In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism III: Nursing Management